These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 10707575)

  • 1. [Insulin resistance in pituitary, thyroid, and adrenal diseases].
    Iitaka M; Katayama S
    Nihon Rinsho; 2000 Feb; 58(2):451-5. PubMed ID: 10707575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction of insulin resistance in methimazole-treated patients with Graves disease.
    Tene C; Zárate A; Basurto L; Islas S; Revilla C; Ochoa R; Galván R; Santos P
    Rev Invest Clin; 2001; 53(6):531-5. PubMed ID: 11921526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormonal diagnosis of GH hypersecretory states.
    Grottoli S; Gasco V; Ragazzoni F; Ghigo E
    J Endocrinol Invest; 2003; 26(10 Suppl):27-35. PubMed ID: 15497657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-sensitizing effect of rosiglitazone (BRL-49653) by regulation of glucose transporters in muscle and fat of Zucker rats.
    Kramer D; Shapiro R; Adler A; Bush E; Rondinone CM
    Metabolism; 2001 Nov; 50(11):1294-300. PubMed ID: 11699047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid hormone excess increases basal and insulin-stimulated recruitment of GLUT3 glucose transporters on cell surface.
    Dimitriadis G; Maratou E; Alevizaki M; Boutati E; Psara K; Papasteriades C; Raptis SA
    Horm Metab Res; 2005 Jan; 37(1):15-20. PubMed ID: 15702433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].
    Robaczyk MG
    Ann Acad Med Stetin; 2002; 48():283-300. PubMed ID: 14601484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance in type II diabetes mellitus.
    Rizza R; Butler P
    Adv Second Messenger Phosphoprotein Res; 1990; 24():511-6. PubMed ID: 2169826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid hormone modulates insulin-like growth factor-I(IGF-I) and IGF-binding protein-3, without mediation by growth hormone, in patients with autoimmune thyroid diseases.
    Inukai T; Takanashi K; Takebayashi K; Fujiwara Y; Tayama K; Takemura Y
    Horm Metab Res; 1999 Oct; 31(10):576-9. PubMed ID: 10596968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A; Murray RD; Teasdale GM; Shalet SM
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine problems of adolescent pregnancy.
    Molitch ME
    Endocrinol Metab Clin North Am; 1993 Sep; 22(3):649-72. PubMed ID: 8243453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calorie restriction improves whole-body glucose disposal and insulin resistance in association with the increased adipocyte-specific GLUT4 expression in Otsuka Long-Evans Tokushima fatty rats.
    Park SY; Choi GH; Choi HI; Ryu J; Jung CY; Lee W
    Arch Biochem Biophys; 2005 Apr; 436(2):276-84. PubMed ID: 15797240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Glucose intolerance in thyroid diseases].
    Iitaka M
    Nihon Rinsho; 2002 Jul; 60 Suppl 7():697-702. PubMed ID: 12238120
    [No Abstract]   [Full Text] [Related]  

  • 14. Green tea supplementation ameliorates insulin resistance and increases glucose transporter IV content in a fructose-fed rat model.
    Wu LY; Juan CC; Hwang LS; Hsu YP; Ho PH; Ho LT
    Eur J Nutr; 2004 Apr; 43(2):116-24. PubMed ID: 15083319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRH in Cushing's syndrome.
    Müller OA; Stalla GK; von Werder K
    Horm Metab Res Suppl; 1987; 16():51-8. PubMed ID: 2832289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-mediated pseudoacromegaly in a patient with severe insulin resistance: association of defective insulin-stimulated glucose transport with impaired phosphatidylinositol 3-kinase activity in fibroblasts.
    Kausch C; Bergemann C; Hamann A; Matthaei S
    Exp Clin Endocrinol Diabetes; 1999; 107(2):148-54. PubMed ID: 10320056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Glucose intolerance due to diseases of the pituitary].
    Suzuki S
    Nihon Rinsho; 1998 Jan; 56 Suppl 3():629-35. PubMed ID: 9513489
    [No Abstract]   [Full Text] [Related]  

  • 18. Is there any relation between hyperinsulinemia, insulin resistance and colorectal lesions in patients with acromegaly?
    Foltyn W; Kos-Kudla B; Strzelczyk J; Matyja V; Karpe J; Rudnik A; Marek B; Kajdaniuk D; Sieron A; Latos W
    Neuro Endocrinol Lett; 2008 Feb; 29(1):107-12. PubMed ID: 18283256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examination of the direct effects of metabolic factors on somatotrope function in a non-human primate model, Papio anubis.
    Luque RM; Gahete MD; Valentine RJ; Kineman RD
    J Mol Endocrinol; 2006 Aug; 37(1):25-38. PubMed ID: 16901921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure?
    Damjanovic SS; Neskovic AN; Petakov MS; Popovic V; Macut D; Vukojevic P; Joksimovic MM
    Clin Endocrinol (Oxf); 2005 Apr; 62(4):410-7. PubMed ID: 15807870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.